These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 15796056)

  • 1. [Therapies for intractable respiratory infection due to Pseudomonas aeruginosa].
    Nasu M
    Nihon Naika Gakkai Zasshi; 2005 Feb; 94 Suppl():51-5. PubMed ID: 15796056
    [No Abstract]   [Full Text] [Related]  

  • 2. [Suppressive effects of macrolides and their derivatives on quorum sensing systems in Pseudomonas aeruginosa].
    Tateda K; Ishii Y; Yamaguchi K; Horikawa M; Ishikuro M
    Jpn J Antibiot; 2003 Feb; 56(1):80-6. PubMed ID: 12723402
    [No Abstract]   [Full Text] [Related]  

  • 3. Pseudomonas aeruginosa chronic colonization in cystic fibrosis patients.
    Murray TS; Egan M; Kazmierczak BI
    Curr Opin Pediatr; 2007 Feb; 19(1):83-8. PubMed ID: 17224667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Drug therapy of intractable Pseudomonas infections].
    Tanimoto S
    Nihon Naika Gakkai Zasshi; 1990 Dec; 79(12):1669-73. PubMed ID: 1981892
    [No Abstract]   [Full Text] [Related]  

  • 5. [Quorum-sensing system of Pseudomonas aeruginosa--a novel target for antibacterial agents].
    Tateda K; Ishii Y; Yamaguchi K
    Nihon Saikingaku Zasshi; 2004 Nov; 59(4):543-9. PubMed ID: 15646084
    [No Abstract]   [Full Text] [Related]  

  • 6. Role of LecA and LecB lectins in Pseudomonas aeruginosa-induced lung injury and effect of carbohydrate ligands.
    Chemani C; Imberty A; de Bentzmann S; Pierre M; Wimmerová M; Guery BP; Faure K
    Infect Immun; 2009 May; 77(5):2065-75. PubMed ID: 19237519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Application of macrolides to diffuse panbronchiolitis].
    Kudoh S
    Nihon Rinsho; 2007 Feb; 65 Suppl 2 Pt. 1():554-8. PubMed ID: 17455680
    [No Abstract]   [Full Text] [Related]  

  • 8. [Long-term effect of erythromycin therapy on Pseudomonas aeruginosa in chronic murine model of pseudomonas pulmonary infection].
    Nagata T; Mukae H; Kadokawa T; Kaida H; Kuroki M; Yanagihara K; Asano K; Kadota J; Koji T; Kawano S
    Jpn J Antibiot; 2003 Apr; 56 Suppl A():57-9. PubMed ID: 14679749
    [No Abstract]   [Full Text] [Related]  

  • 9. [Quorum-sensing systems in bacteria].
    Tateda K
    Nihon Rinsho; 2003 Mar; 61 Suppl 3():272-9. PubMed ID: 12717983
    [No Abstract]   [Full Text] [Related]  

  • 10. Pathogenesis and clinical manifestations of chronic colonization by Pseudomonas aeruginosa and its biofilms in the airway tract.
    Kobayashi H; Kobayashi O; Kawai S
    J Infect Chemother; 2009 Jun; 15(3):125-42. PubMed ID: 19554398
    [No Abstract]   [Full Text] [Related]  

  • 11. [Bacterial biofilms].
    Tanaka H
    Nihon Naika Gakkai Zasshi; 2006 Nov; 95(11):2251-5. PubMed ID: 17168401
    [No Abstract]   [Full Text] [Related]  

  • 12. Impact of the duration of antibiotics on clinical events in patients with Pseudomonas aeruginosa ventilator-associated pneumonia: study protocol for a randomized controlled study.
    Bouglé A; Foucrier A; Dupont H; Montravers P; Ouattara A; Kalfon P; Squara P; Simon T; Amour J;
    Trials; 2017 Jan; 18(1):37. PubMed ID: 28114979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antipseudomonic effect of macrolides. Experience in a case of nosocomial pneumonia caused by multidrug-resistant Pseudomonas aeruginosa without response to antibiotic therapy].
    Barbero JM; Arranz A; Rebollar A; Culebras A; García M; Agudo R; Pérez L; Montero E
    Rev Esp Quimioter; 2018 Feb; 31(1):72-74. PubMed ID: 29390604
    [No Abstract]   [Full Text] [Related]  

  • 14. Risk factors for Pseudomonas aeruginosa pneumonia in the early twenty-first century.
    Rello J; Borgatta B; Lisboa T
    Intensive Care Med; 2013 Dec; 39(12):2204-6. PubMed ID: 24146002
    [No Abstract]   [Full Text] [Related]  

  • 15. Pseudomonas aeruginosa Biofilms: Host Response and Clinical Implications in Lung Infections.
    Maurice NM; Bedi B; Sadikot RT
    Am J Respir Cell Mol Biol; 2018 Apr; 58(4):428-439. PubMed ID: 29372812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of azithromycin on the virulence of Pseudomonas aeruginosa].
    Reinert P
    Pathol Biol (Paris); 1995 Jun; 43(6):551-3. PubMed ID: 8539081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunotherapy with monovalent Pseudomonas aeruginosa vaccine in chronic respiratory infections.
    Popescu C; Meitert E; Rusu R; Meitert T; Sima F; Savulian C
    Arch Roum Pathol Exp Microbiol; 1982; 41(3):265-76. PubMed ID: 6818929
    [No Abstract]   [Full Text] [Related]  

  • 18. Antiadhesive properties of glycoclusters against Pseudomonas aeruginosa lung infection.
    Boukerb AM; Rousset A; Galanos N; Méar JB; Thépaut M; Grandjean T; Gillon E; Cecioni S; Abderrahmen C; Faure K; Redelberger D; Kipnis E; Dessein R; Havet S; Darblade B; Matthews SE; de Bentzmann S; Guéry B; Cournoyer B; Imberty A; Vidal S
    J Med Chem; 2014 Dec; 57(24):10275-89. PubMed ID: 25419855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of developing pneumonia is enhanced by the combined traits of fluoroquinolone resistance and type III secretion virulence in respiratory isolates of Pseudomonas aeruginosa.
    Sullivan E; Bensman J; Lou M; Agnello M; Shriner K; Wong-Beringer A
    Crit Care Med; 2014 Jan; 42(1):48-56. PubMed ID: 23963124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiological and immunobiological implications of Pseudomonas aeruginosa epidemiological markers.
    Meitert T; Meitert E
    Arch Roum Pathol Exp Microbiol; 1981; 40(1):5-23. PubMed ID: 6821022
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.